ZA925492B - Immunoassay for the simultaneous detection of hiv-1,hiv-2,htlv-i and htlv-ii antibodies - Google Patents

Immunoassay for the simultaneous detection of hiv-1,hiv-2,htlv-i and htlv-ii antibodies

Info

Publication number
ZA925492B
ZA925492B ZA925492A ZA925492A ZA925492B ZA 925492 B ZA925492 B ZA 925492B ZA 925492 A ZA925492 A ZA 925492A ZA 925492 A ZA925492 A ZA 925492A ZA 925492 B ZA925492 B ZA 925492B
Authority
ZA
South Africa
Prior art keywords
htlv
hiv
immunoassay
antibodies
simultaneous detection
Prior art date
Application number
ZA925492A
Other languages
English (en)
Inventor
Martial Lacroix
Lacroix Martial
Robert J Dwyer
J Dwyer Robert
Maan Zrein
Zrein Maan
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of ZA925492B publication Critical patent/ZA925492B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA925492A 1991-07-29 1992-07-21 Immunoassay for the simultaneous detection of hiv-1,hiv-2,htlv-i and htlv-ii antibodies ZA925492B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73707291A 1991-07-29 1991-07-29

Publications (1)

Publication Number Publication Date
ZA925492B true ZA925492B (en) 1993-04-28

Family

ID=24962471

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925492A ZA925492B (en) 1991-07-29 1992-07-21 Immunoassay for the simultaneous detection of hiv-1,hiv-2,htlv-i and htlv-ii antibodies

Country Status (15)

Country Link
EP (1) EP0605433B1 (de)
JP (1) JP2931100B2 (de)
CN (1) CN1070484A (de)
AT (1) ATE132268T1 (de)
AU (1) AU2340992A (de)
CA (1) CA2114220A1 (de)
DE (1) DE69207200T2 (de)
EG (1) EG20183A (de)
ES (1) ES2085631T3 (de)
IE (1) IE922452A1 (de)
IL (1) IL102615A (de)
NZ (1) NZ243636A (de)
PT (1) PT100731B (de)
WO (1) WO1993003376A1 (de)
ZA (1) ZA925492B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2125467C (en) * 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
WO1995033206A1 (en) * 1994-05-31 1995-12-07 Abbott Laboratories Detection of different hiv genotypes utilizing a synthetic peptide-modified immunoassay
US5695930A (en) * 1994-11-10 1997-12-09 Weinstein; David E. HIV test kit method for detecting anti-HIV-I antibodies in saliva
US5977299A (en) * 1997-04-07 1999-11-02 Dade Behring Marburg Gmbh Activated peptides and conjugates
EP0993615A1 (de) * 1998-03-04 2000-04-19 Universal Healthwatch, Inc. Schnelltest für mikrobielle infektionen
FR2839555B1 (fr) 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
CN103713127A (zh) * 2014-01-01 2014-04-09 武汉翰雄生物技术有限公司 一种人类嗜t细胞病毒酶联检测试剂盒
CN108387726A (zh) * 2018-01-13 2018-08-10 中国医学科学院医学生物学研究所 脊髓灰质炎病毒ⅰ、ⅱ、ⅲ型d抗原同步快速鉴别、定量检测方法及其检测试剂盒和应用
CN108241058A (zh) * 2018-01-13 2018-07-03 中国医学科学院医学生物学研究所 一种脊髓灰质炎病毒ⅲ型d抗原预包被检测方法及其检测试剂盒和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0136798A3 (de) * 1983-08-25 1986-02-19 Biotech Research Laboratories Inc. Titrierungsplatte und Testsatz zum Nachweis von Antikörpern in menschlichem Serum und ihre Herstellung und Verwendung
US5039604A (en) * 1987-08-21 1991-08-13 Cellular Products, Inc. Test device and method of preparing same, assay kit and method for the simultaneous detection of two HTLV or HIV antibodies
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
ATE116660T1 (de) * 1989-01-13 1995-01-15 United Biomedical Inc Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1.

Also Published As

Publication number Publication date
IL102615A0 (en) 1993-01-14
ATE132268T1 (de) 1996-01-15
IL102615A (en) 1997-04-15
ES2085631T3 (es) 1996-06-01
NZ243636A (en) 1993-06-25
JPH06509868A (ja) 1994-11-02
EG20183A (en) 1997-09-30
AU2340992A (en) 1993-03-02
EP0605433A1 (de) 1994-07-13
PT100731B (pt) 1999-07-30
IE922452A1 (en) 1993-02-10
PT100731A (pt) 1993-10-29
EP0605433B1 (de) 1995-12-27
DE69207200T2 (de) 1996-08-22
WO1993003376A1 (en) 1993-02-18
JP2931100B2 (ja) 1999-08-09
CA2114220A1 (en) 1993-02-18
DE69207200D1 (de) 1996-02-08
CN1070484A (zh) 1993-03-31

Similar Documents

Publication Publication Date Title
CA2033168A1 (en) Method of Optical Analysis
HK124293A (en) Diagnostic kit and method for rapid detection of antibodies
DE68919245D1 (de) Verfahren zum Nachweis von Endotoxin.
DE69022286D1 (de) Reagenzien, Verfahren und Testsätze zum Nachweis von Amphetaminen durch einen Fluoreszenz-Polarisations-Immunoassay.
ES2010316A6 (es) Dispositivo y equipo de ensayo y metodo de preparacion del mismo.
CA2022942A1 (en) Method of assessing sensitivity of hiv to zidovudine
YU46053B (sh) Postopek za specifično določanje vsebnosti serumskega fruktozamina
ATE133206T1 (de) Verfahren zum nachweis von bakterien im harn
EG20183A (en) Immunoassay for the simultaneous detection of HIV-1 HTLV2 HTLV-1 and HTLV-II-antibodies
AU6727798A (en) Method for simultaneous detection of hiv antigens and hiv antibodies
AU2314088A (en) Method for rapid and sensitive detection of igm retroviral antibodies
SE8900721D0 (sv) Methods for detection of antibodies to
EP0248534A3 (de) Verfahren zum Nachweis einer AIDS-Virus-Infektion
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
ES2177547T3 (es) Metodo gradual para detectar la enfermedad de chagas y reactivos utilizados en tales efectos.
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
WO1990009594A3 (en) Wash composition, test kit and their use to determine a herpes simplex viral antigen
DE68919387D1 (de) DNS- und RNS-Proben, Methoden und Testsätze zum Nachweis von Salmonella.
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ES2134810T3 (es) Diferenciacion de htlv-i y htlv-ii con la ayuda de peptidos sinteticos.
EP0322922A3 (de) Nachweis von Injektionen des Vogel- und Säugetier-Retrovirus
ATE130050T1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.
AU3171797A (en) Process to eliminate haemoglobin errors during the determination of albumin
ATE142342T1 (de) Benutzung von sp-2 monoklonalen antikörpern zur diagnostik und zur beobachtung des hiv- infektionsfortschritts